TOP NEWS Blood clots should be listed as rare Johnson & Johnson side effect: EMA Blood clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday. AFP Read More
Growing concerns as Nigeria pivots from AstraZeneca to J&J COVID-19 vaccine Timileyin Omilana Read More
‘How science reporting can drive sustainable development goals’ Marcel Mbamalu, Kigali-Rwanda Read More